The United States will give up the vaccine intellectual property patent, why is Germany objecting?

The United States will give up its vaccine intellectual property patents, but Germany is the first to object, which seems to be unreasonableBecause the relationship between the United States and Germany and other European countries has always been very good, it stands to reason that it is not a good thing for countries all over the world to have free vaccine patents, why should Germany oppose it, and it is not willing to offend its own partners. In fact, to understand why Germany and the United States made such a decision, we must first understand the current state of the United States, as we all know, since the outbreak of the epidemic, the vast majority of countries in the world have been affected, especially in terms of economy, as the world's largest economic power, the United States has not handled the epidemic very well, therefore, its economy has also been affected to a certain extent. <>

It can be said that the United States today urgently needs cheap global products to alleviate its own inflationary pressuresDue to the aggravation of the epidemic situation in India, the world's second largest world communist is in a state of semi-shutdown, coupled with a series of tariffs imposed by the United States on China before, which has led to a sharp rise in prices in the United States, although the United States has also taken some measures, the most obvious is to vigorously print money, although the paper money has increased, but the items have not increased, in the long run, it will naturally cause inflation, and the harm to other countries is not low, therefore, the United States urgently needs the global epidemic situation to be controlled, In particular, the epidemic situation in developing countries cannot be worsened, and if it worsens, then its product chain will change, which will have a huge impact on the US economy. <>

Even if we don't start from the perspective of the United States, but from the perspective of all countries in the world, wouldn't it be good for the whole world if the epidemic situation improves, so why would Germany oppose this move by the United States? This is because even if the United States liberalizes the patent rights of vaccines, the production of vaccines will always be so fast, and if the production of vaccines is accelerated, it will be difficult to ensure the quality of vaccine productionAfter all, it is free, and if the vaccine mutates, then maybe no company will be willing to develop the vaccine, because even if it is developed, there will be no profit in the end, which increases the uncertainty of the rest of the world. <>

Everything is based on self-interest, and nothing is unprofitable from the starting point, so perhaps we can understand the behavior of the United States and Germany.

This is because Germany feels that the US vaccine is still relatively safe, and the two countries also have a relatively good cooperative relationship.

Personally, I think the reason why Germany is objecting is because he thinks that this is not conducive to epidemic prevention and control.

I think it's because Germany is a country that pays special attention to the protection of intellectual property rights, and Germany believes that protecting its intellectual property rights can make its country relatively safe and secure. Moreover, if the patents are protected, Germany will also benefit financially.

Because after the United States did this, the United States was in the United States, and other countries were in the United States, and they suffered losses.

Germany, the main Germany, believes that the withdrawal of the United States is not beneficial to their development, so they do not want the United States to withdraw and express their opposition.

We all know that Germany has always been a country that pays attention to the protection of patents, and it is precisely because of the concept of patent protection that Made in Germany is famous all over the world.

Germany's opposition to the U.S. proposal to abandon patent protection for coronavirus vaccines said in an email that the U.S. plan would cause "serious trouble" for vaccine production. German Chancellor Angela Merkel has opposed the U.S. proposal to abandon patent protection for the coronavirus vaccine, and industry insiders believe that if there is no profit incentive behind it, drugmakers may not actively produce vaccines in the future.

Profit is the driving factor

After Merkel's statement, vaccine stocks**. Curevac NV**, with the highest intraday decline of 13%, and BioNTech SE**, at one point**15%.

In the coming weeks, the United States, Germany and other countries and regions will discuss the idea of patent exemptions in the context of the urgent need for the world, especially developing countries, to increase production capacity through the debate on patent protection exemptions through the World ** Organization. Merkel's position shows that she has sympathy for pharmaceutical companies like biotech.

Some** said that such discussions could take several months, and that only a few patents could end up being exempted. It is almost impossible for the EU and the US to agree to give up the intellectual property rights of the mRNA technology revolution to other countries. However, most of the world's poor countries have neither the capacity nor the expertise to produce this advanced vaccine.

A more immediate solution, we said, would be for the US, UK and other countries to follow the EU's lead and lift restrictions on vaccine exports to countries in need.

With the increase in vaccinations in the United States and the easing of the pandemic in recent weeks, especially when both deaths and infections from COVID have risen dramatically, the White House has come under pressure from progressive Democrats and public health advocates to take an immediate stand.

Well, that's all for this issue.

Because the patent was originally German, the waiver of patent protection by the United States means that it does not respect the results of German research and is not conducive to Germany's economic income.

Because Germany feels that intellectual property is particularly important and is the driving force of innovation, and without innovation, a country will lose its economic development, and this is the main reason.

It is understood that after the United States proposed to temporarily abandon the patent rights of the new crown vaccine, European Commission President von der Leyen said about itBe open-minded”。EU and European leaders are expected to discuss this issue at their summit this Friday.

On May 6, local time, a spokesman for Germany** said that the U.S. plan would bring "serious trouble" to vaccine production. According to Bloomberg, drugmakers may not develop and manufacture vaccines in the future without the incentive of profits from R&D.

A spokesman for Germany** said that the factors limiting the production of the new crown vaccine are production capacity and high quality standards, not patents. She stressed that IP protection was a source of innovation.

German Federal Development Minister Müller also criticized the aggressive attitude of the United States. He also called on the United States to help ensure vaccine production.

China will support the focus on vaccine accessibility:

For the United States to abandon the new crown vaccine patent initiative, the attitude of countries is different, then the same vaccine power, China responded on May 6 that China will support the focus on the issue of vaccine accessibility, but also look forward to the WTO framework to actively engage in constructive discussions, and strive to achieve an effective and balanced result.

In fact, China has already made a lot of contributions to the fairness of global vaccine distribution, and as of March 23, it has provided vaccine assistance to 80 countries and three international organizations around the world. It is worth mentioning that the Chinese vaccine is also expected to be available in Europe to help the region's vaccination. On May 4, the European Medicines Agency announced that it would evaluate the Sinovac vaccine.

The above content refers to the global network Germany rejected the US proposal to give up the new crown vaccine patent.

The US ZF supports the abandonment of the new crown vaccine patent protection proposal, completely fooling the people of the world!

The patent right of the new crown vaccine in the United States is not in ZF, but in the pharmaceutical company, ZF proposes - to give it up concretely, the cycle is too long, an inefficient state administration, and the daylily is cold! The United States is just making a gesture, and there are a group of drummers in the world who sing praises to it.

The pandemic is the worst health crisis ever faced, and it is no less harmful to humanity than a world war. Those politicians in the United States and the West are still dealing with the same old-fashioned governance, which is destined to be "one wave higher than another"! First the United States, Europe, now India, the next may be Southeast Asia-South Asia, and then the next wave may be Africa, or even return to Europe and the United States.

Those in the international community who think that they will win the battle against the epidemic by relying on vaccines are just wishful thinking!

Back to Germany, opposing the United States to abandon the topic of patent protection for the new crown vaccine. By the time the patent rights are waived, there are only a few countries and pharmaceutical companies in the world that can produce new crown vaccines, and after the time limit, the vaccine will be meaningless!

So, when I saw this news, I felt unreliable!

A few days ago, in response to the call of the United States to give up the patent of the new crown vaccine, all walks of life in Germany expressed doubts and opposition. In response to Germany's opposition to the United States' proposal to abandon patent protection for the new crown vaccineSome netizens said that the patent was originally German. Some netizens also said that the United States supports the appearance of a big brother for free, and it is understandable that Germany opposes it.

A German spokesman said on the 6th that the U.S. plan to abandon the new crown vaccine is of great significance to the entire vaccine production. But the protection of intellectual property rights is a source of innovation and must be so in the future. Germany stressed that production capacity and quality control were the main obstacles to expanding access to vaccines, not intellectual property rights.

The U.S. has waived patent protection for COVID vaccines

On May 5, Biden issued a decision saying that the United States supports the waiver of intellectual property patents for the new crown vaccine. U.S. Secretary of State Antony Blinken said that patent waivers are one of the various means that the United States** is considering to strengthen the fight against the epidemic.

This attitude has changed 180 degrees from the previous statements of the United States. Previously, developing countries led by South Africa and India, and developed countries led by the United States and the European Union "quarreled" for months over whether to temporarily exempt the intellectual property rights of the new crown vaccine.

WHO Director-General Tedros Adhanom Ghebreyesus hailed the U.S. decision as "a milestone in the fight against the coronavirus" and reflects the "moral leadership" of the U.S. in the fight to end the pandemic.

However, the White House's support does not guarantee that the vaccine patent waiver will be granted. According to the New York Times, changes in international intellectual property rules require the unanimous consent of all parties in the WTO. The next step for the WTO is to finalize an agreement on intellectual property waivers, a process that could take months.

I do not support this proposal because the United States has given up patent protection, cannot increase vaccine production, and does not play a role in epidemic prevention and control.

Since the development of the epidemic, many countries have invested in vaccine research, including the United States, China, Europe and other countries. The U.S. proposal to abandon patent protection for COVID vaccines is a well-intentioned idea, but it does not help prevent and control the epidemic. The production of vaccines requires extremely complex processes, and it is not possible to release patents and produce them in other countries, and giving up patent protection will lead to a decline in corporate profitability and reduce the motivation for vaccine production, which is not conducive to epidemic prevention and control.

Germany argues that this would affect the industry's development and opposes the US proposal to abandon patent protection for the coronavirus vaccine. <>

First, the production of vaccines is complex, and abandoning patent protection will not increase production. The production of vaccines is very complex, it requires specialized factories, it takes a long time to build these factories, and the key to producing vaccines lies in equipment and raw materials. The waiver of patent protection by vaccine manufacturers will not increase vaccine production much and will not play a role in epidemic prevention and control.

Second, giving up patent protection is not beneficial to the enterprise and will reduce the production of the enterprise. Pharmaceutical companies have invested huge amounts of capital in the research and development of new drugs and vaccines, and if they give up protecting vaccine patents, then the company cannot be protected, and other pharmaceutical companies can imitate drugs, and the company's profitability will be reduced. In this case, companies will reduce the production of vaccines.

In the case that vaccine production has not been fully rolled out, manufacturers have reduced their desire to produce, which is not conducive to increasing vaccine production and preventing and controlling the global epidemic. <>

3. Patent protection is beneficial to the development of the industry, and decisions should be made carefully. Patent protection has a strong protective effect on the pharmaceutical industry, which can motivate pharmaceutical companies to invest in R&D, once patent protection is abandoned, it will affect the enthusiasm of enterprises, and in the long run, the development of the entire industry will be affected. As a result, the U.S. proposal was opposed by Germany, which argued that it was prudent to abandon patent protection in the long run.

I support such a proposal. Because I think the pandemic is a worldwide problem right now. It's not a national thing. I think that the new crown vaccine has been developed and should be shared with other countries.

I don't support this proposal because the U.S. vaccine is not particularly stable, so the U.S. drops the COVID vaccine patent, and I think there may be a conspiracy.

I support this proposal because teams in many countries across the country have developed vaccines, and if you apply for a patent, you will not be copied in your own country.

In the tank. Because in this way, it is still very fair for some countries, and some patent rights can be better protected.

Germany opposes the newly adopted request of the United States to give up the new crown vaccine patent, which is not only opposed by Germany, but also by many countries around the worldBecause this patent problem cannot solve the dilemma of the world epidemic, because the key to the production of vaccines is not the formula, but the raw materials. <>

Because the formula is a lot of private companies have spent a lot of effort to research, we are funded by the state to research this thing, free for the public to use, but not abroad, many foreign vaccines are developed and related to large private pharmaceutical companies, to put it bluntly, people have invested tens of billions of dollars to research this thing, you are now a sentence to let people give up patents, people will give up? If I invest so much money, who will make up for me, it will definitely affect the enthusiasm of these pharmaceutical companies to produce vaccines. <>

Even if people can't oppose you from the surface, let me not have enough production capacity, originally driven by the market, people have to make money, then maybe they can produce 100 million vaccines a month, but now you want me to give up the patent, I don't have to make money or even earn, and even say that I still lose money, then I'm sorry that the production line of the platform is not so strong, the personnel are not enough and the talent is not enough, anyway, I can't produce so much for a random reason, it will only cause a vicious circle, because which factory do you let do the things that don't make money, Why do people do business and not charity?People have spent tens of billions of dollars to research something, you can't make people give up in one sentence. <>

This kind of behavior is generosity, which means that. Now there are two people selling steamed buns on the street, the steamed buns I make are more delicious, and he also makes steamed buns, but the steamed buns he makes are not very delicious, and then now there are some poor people on the street, and people can't afford to buy steamed buns. I can donate a portion of it appropriately, but the person who made the bag is not delicious said,Let's publish the recipe of the buns, don't hold your own personal interests, this is to smash other people's jobs and be generous to others.